Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial (2022)

First Author: Wallis R

Attributed to: Epidemiological and statistical research on health problems of low and middle-income countries: MRC Tropical Epidemiology Group (TEG) funded by MRC

No abstract provided

Type: Journal Article/Review

Parent Publication: PLOS ONE

Issue: 2